Back
T-Mobile US Vs. Crinetics Pharmaceuticals Industry Stock Comparison
Buy
55
TMUS
T-Mobile US
Last Price:
$211.25
Seasonality Move:
10.09%
Sell
8
CRNX
Crinetics Pharmaceuticals
Last Price:
$40.59
Seasonality Move:
-9.08%
Buy
55
T-Mobile US (TMUS)
is a Buy
Is T-Mobile US a Buy, Sell or Hold?
-
The current T-Mobile US [TMUS] share price is $215.52. The Score for TMUS is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
TMUS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
8
Crinetics Pharmaceuticals (CRNX)
is a Sell
Is Crinetics Pharmaceuticals a Buy, Sell or Hold?
-
The current Crinetics Pharmaceuticals [CRNX] share price is $48.50. The Score for CRNX is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
TMUS Stock Price Chart
What is T-Mobile US's stock price today?
-
The T-Mobile US share price today is $215.52Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TMUS is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals's stock price today?
-
The Crinetics Pharmaceuticals share price today is $48.50Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing slight selling pressure.
TMUS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.72 | Sell |
Relative Strength Index (14 RSI): | 35.1 | Sell |
Chaikin Money Flow: | 2644267 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (216.67 - 236.01) | Sell |
Bollinger Bands (100): | (202.83 - 233.79) | Sell |
CRNX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.69 | Sell |
Relative Strength Index (14 RSI): | 34.32 | Sell |
Chaikin Money Flow: | -235099 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.1 - 56.94) | Sell |
Bollinger Bands (100): | (51.5 - 57.46) | Sell |
TMUS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 217.91 | Sell |
20-day SMA: | 222.69 | Sell |
50-day SMA: | 230.53 | Sell |
200-day SMA: | 195.49 | Buy |
8-day EMA: | 217.25 | Sell |
20-day EMA: | 222.33 | Sell |
50-day EMA: | 224.6 | Sell |
200-day EMA: | 201.3 | Buy |
CRNX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.85 | Sell |
20-day SMA: | 53.18 | Sell |
50-day SMA: | 55.63 | Sell |
200-day SMA: | 51.03 | Sell |
8-day EMA: | 50.82 | Sell |
20-day EMA: | 52.67 | Sell |
50-day EMA: | 54.22 | Sell |
200-day EMA: | 49.96 | Sell |
T-Mobile US Earnings Growth & TMUS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.95 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $2.11 per share.
Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.
T-Mobile US Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Crinetics Pharmaceuticals Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |